According to a recent study, psoriasis patients with intermediate skin phenotypes and a history of phototherapy had a higher risk of excessive sun exposure risk.
Lower drug survival rates for female PsO patients
According to a recent study, female psoriasis patients have shorter drug survival for biologics compared to men.
Study shows unmet need with frequent flares in PsO patients
According to a recent study, patients with generalized pustular psoriasis experience frequent flares that are typically uncontrolled by off-label therapies.
Body roundness linked to increased risk of psoriasis
According to a recent study, an increased Body Roundness Index score, an indicator of abdominal obesity, is associated with an increased risk of psoriasis.
Study shows induction therapy with ixekizumab may lower drug survival
According to a recent study, induction therapy with ixekizumab in patients with moderate-to-severe plaque psoriasis may offer faster symptom relief but shows lower long-term drug survival.
Recent study suggests plant-rich diets with low saturated fats may be associated with reduced PsO severity
According to a recent study, healthier eating patterns may be linked to psoriasis severity.
Oral roflumilast efficacious in treating moderate-to-severe plaque PsO
According to a recent real-world study, oral roflumilast was efficacious in reducing disease severity in moderate-to-severe plaque psoriasis.
Inflammation may be linked to stomach problems in psoriasis patients
According to a recent study, inflammation in psoriasis patients may be tied to stomach problems.
New study links stress and psoriasis relapse
According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).
Home-based narrowband UV-B phototherapy for PsO as effective as office-based treatment
According to a recent study, home-based narrowband UV-B phototherapy for plaque and guttate psoriasis is as effective as office-based treatments.
